Showing results (1-10 of 365) with videos related to

Sort By:
Pageof 37
Hepatology Communications|February 7, 2018
A global perspective on hepatitis B-related single nucleotide polymorphisms and evolution during human migrationDar-In Tai, Wen-Juei Jeng, Chun-Yen Lin
Viruses|April 23, 2022
Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting AntiviralsCheng-Er Hsu, Yen-Chun Liu, Ya-Ting Cheng, et al.
Digestive Diseases and Sciences|July 27, 2022
Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C PatientsYen-Chun Liu, Ya-Ting Cheng, Yi-Cheng Chen, et al.
BMC Gastroenterology|May 14, 2020
Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective studyYi-Cheng Chen, Wen-Juei Jeng, Chao-Wei Hsu, et al.
Digestive Diseases and Sciences|February 11, 2021
Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B PatientsYi-Cheng Chen, Chao-Wei Hsu, Wen-Juei Jeng, et al.
Plos One|August 24, 2018
Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosisYi-Chung Hsieh, Wen-Juei Jeng, Chien-Hao Huang, et al.
Annals of Hepatology|May 19, 2026
Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradicationYen-Chun Liu, Te-Sheng Chang, Chi-Yi Chen, et al.
European Journal of Gastroenterology & Hepatology|November 12, 2020
Combining immune checkpoint inhibitor with lenvatinib prolongs survival than lenvatinib alone in sorafenib-experienced hepatocellular carcinoma patientsPo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Adjuvant therapy for hepatocellular carcinoma after curative treatmentWen-Juei Jeng, Chen-Chun Lin, Wei-Ting Chen, et al.
Plos One|November 23, 2012
None of the six SNPs of IL28B could predict treatment responses in genotype 2 chronic HCV infected patients by propensity score matching analysisWen-Juei Jeng, Chun-Yen Lin, Ji-Yih Chen, et al.
Pageof 37